Author

Laurie Exposito

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Ashaina VandenbergheiD· 1 shared Aussel Anaïs· 1 shared Cédric ChaverouxiD· 1 shared Dorat Noémie· 1 shared Edmond ChicheiD· 1 shared Ivan NemazanyyiD· 1 shared Jean‐Ehrland RicciiD· 1 shared Johanna ChicheiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ashaina VandenbergheORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

L-asparaginase treatment induces a tumor metabolic plasticity and reveals a vulnerability to PARP1/2 inhibitor Olaparib, in B-cell lymphomas.

Aussel Anaïs, Ivan Nemazanyy, Ashaina Vandenberghe, Pauline Meola, Dorat Noémie, Rachel Paul, Lama Habbouche, Laurie Exposito, Nicolas Nottet, Virginie Pétrilli, Edmond Chiche, Nicolas Mounier, Sandrine Marchetti, Cédric Chaveroux, Jean‐Ehrland Ricci, Johanna Chiche

This study shows that L-asparaginase treatment induces metabolic plasticity in B-cell lymphomas, making them vulnerable to PARP1/2 inhibitor Olaparib, with potential broader therapeutic applications.

bioRxiv · Oct 24, 2025 · PreprintCancer Biology